A Review Of ARQ 531
In this examine we examined the exercise of cefepime/zidebactam (WCK 5222) against consecutive reference laboratory submissions of Gram-destructive germs, taken as a sample of issue strains circulating in the united kingdom.The stability of cefepime from AmpC, when combined with an ESBL-Lively BLI, presents the protection of AmpC and ESBL coproduce